Crossmark

Successful treatment of systemic EBV-positive T-cell lymphoma of childhood using the ruxolitinib combined with L-DEP regimen chemotherapy followed by haploidentical allogeneic hematopoietic stem cell transplantation

Crossref DOI link: https://doi.org/10.1007/s00277-023-05298-z

Published Online: 2023-07-25

Published Print: 2023-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Jian https://orcid.org/0000-0001-5178-793X
Cao, Chunyan

Lu, Shifeng

Rong, LiuCheng

Kang, Meiyun

Fang, Yongjun
Funding

Funding for this research was provided by:

Natural Science Foundation of Jiangsu Province (BK20211009)

Scientific Research Projects of Jiangsu Health Commission (ZDB2020018)
License Information

Text and Data Mining valid from 2023-07-25

Version of Record valid from 2023-07-25
More Information

Article History

Received: 28 October 2022

Accepted: 20 December 2022

First Online: 25 July 2023

Declarations

:

: This case was published with parents’ informed consent, and the Nanjing Medical University ethics and plan review committee approved the study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below